Company intelligence / Profile preview

LCB Worldwide

Ownership: Private
Development stage: Commercial

Overview

LCB Worldwide is a multinational company specializing in the innovation and operation of prevention solutions and disease control facilities, particularly at international ports and airports. The company's primary focus is on implementing large-scale disinfection systems to prevent cross-border transmission of infectious diseases. Their work supports public health infrastructure by providing mandatory disinfection services at points of entry, aiming to slow down or prevent pandemics through environmental controls rather than pharmaceuticals.

Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on LCB Worldwide.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LCB Worldwide.

Explore the full profile